Literature DB >> 11355052

Evidence-based advertising? A survey of four major journals.

D R Gutknecht1.   

Abstract

BACKGROUND: Pharmaceutical advertisements are an important means of bringing drug information to physicians. Most advertisements are intended only to raise awareness, though there are those that do seek to persuade through presentation of research findings. Researchers have questioned the quality of the research reported in advertisements and wonder whether these advertisements would lead to improper prescribing.
METHODS: A consecutive 6-month sample of advertisements in 4 general medical journals, 3 from the United States and 1 from Canada, were reviewed to determine how research results are presented in pharmaceutical advertisements.
RESULTS: During this time there were 187 distinctive advertisements, with 43 data presentations in the 33 advertisements that contained quantitative research results. These results were examined using a critical appraisal worksheet. References to randomization and blinding were found in less than one half of the 43 data presentations. P values were frequently provided, but confidence intervals and references to power and number needed to treat were not provided in any of the advertisements.
CONCLUSIONS: Descriptions of research in pharmaceutical advertisements were brief and incomplete, and they inconsistently provided the basic design and statistical information needed to judge the results reported. More detail could make these advertisements more meaningful to critical readers.

Mesh:

Substances:

Year:  2001        PMID: 11355052

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  13 in total

1.  Selling drugs to the public--should the UK follow the example of the US?

Authors:  John Frey
Journal:  Br J Gen Pract       Date:  2002-02       Impact factor: 5.386

2.  Selling drugs to doctors--it's marketing, not education.

Authors:  Richelle Cooper; Jerome Hoffman
Journal:  Br J Gen Pract       Date:  2002-02       Impact factor: 5.386

3.  The quantity and quality of scientific graphs in pharmaceutical advertisements.

Authors:  Richelle J Cooper; David L Schriger; Roger C Wallace; Vladislav J Mikulich; Michael S Wilkes
Journal:  J Gen Intern Med       Date:  2003-04       Impact factor: 5.128

4.  Conflicts between commercial and scientific interests in pharmaceutical advertising for medical journals.

Authors:  Alexander C Tsai
Journal:  Int J Health Serv       Date:  2003       Impact factor: 1.663

5.  The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.

Authors:  Richelle J Cooper; David L Schriger
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

6.  Critical appraisal of apparently evidence-based written advertising in Pakistan.

Authors:  Dileep Kumar Rohra; Muhammad Umair Bashir; Ummey Aymen Khwaja; Muhammad Ressam Nazir
Journal:  Pharm World Sci       Date:  2007-10-12

7.  Is content of medical journals related to advertisements? Case-control study.

Authors:  Vasiliy V Vlassov
Journal:  Croat Med J       Date:  2007-12       Impact factor: 1.351

8.  Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States.

Authors:  Noordin Othman; Agnes I Vitry; Elizabeth E Roughead
Journal:  BMC Public Health       Date:  2010-05-29       Impact factor: 3.295

9.  Androgen therapy: testing before prescribing and monitoring during therapy.

Authors:  Alan Katz; Anne Katz; Charles Burchill
Journal:  Can Fam Physician       Date:  2007-11       Impact factor: 3.275

Review 10.  Quality of pharmaceutical advertisements in medical journals: a systematic review.

Authors:  Noordin Othman; Agnes Vitry; Elizabeth E Roughead
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.